UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
admin Belgian biopharmaceutical giant UCB announced Friday a definitive agreement to acquire Neurona Therapeutics, a privately...
biotech
Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
The biopharmaceutical landscape witnessed a flurry of significant developments this past week, ranging from the...
February Marks National Cancer Prevention Month Amidst Alarming Preventable Cancer Statistics
February is recognized annually as National Cancer Prevention Month, a critical period for individuals and...
Kailera Therapeutics Secures $625 Million in Landmark Biotech IPO, Igniting Competition in the Obesity Drug Market
Kailera Therapeutics, a formidable new entrant in the pharmaceutical landscape poised to challenge industry giants...
A Rare Cancer and the Clinical Trial That Saved Her Life
Adrienne Skinner’s journey through a harrowing cancer diagnosis to a life-affirming recovery stands as a...
FDA Plans Advisory Committee Meetings on Peptide Reclassification Amidst Political Scrutiny and Calls for Regulatory Clarity
The Food and Drug Administration (FDA) is set to convene a series of advisory committee...
Eli Lilly’s Foundayo Faces Post-Approval FDA Scrutiny Over Liver Safety Data from Ongoing Diabetes Trial.
Eli Lilly’s newly approved oral obesity medication, Foundayo (orforglipron), has been subjected to significant post-market...
Terremoto raises $108M to pursue development of drugs targeting AKT
California-based Terremoto Biosciences has successfully closed a substantial $75 million Series A financing round, positioning...
Cancer Statistics 2026 Report Reveals Historic Survival Gains Driven by Immunotherapy, Highlights Persistent Disparities
The American Cancer Society’s landmark Cancer Statistics 2026 report paints a compelling picture of both...
Beeline Medicines Debuts with $300 Million Funding and Bristol Myers Squibb Pipeline to Advance Precision Therapies for Autoimmune Diseases.
Emerging from stealth on Wednesday, April 15, 2026, Beeline Medicines announced its official launch, fortified...
